International Clinical Trial: A Multicenter, Prospective, Randomized Controlled Clinical Study Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128710) titled 'A Multicenter, Prospective, Randomized Controlled Clinical Study Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy' on July 24.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

Condition: Newly diagnosed patients with low-risk acute myeloid leukemia

Intervention: Arm C:Daunorubicin+cytarabine Arm A:Lisaftoclax+Daunorubicin+Cytarabine

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-0...